A comprehensive view of sanofi sa. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
New York state attorney general secures deal with Novo Nordisk to cap insulin price at US$35 per monthly prescription for uninsured New Yorkers for five years; the state has similar agreements with Eli Lilly and Sanofi
Published:
September 12, 2023
by US Official News
|
LIB Therapeutics' injectable PCSK9 inhibitor shows promising results in reducing levels of LDL-cholesterol among patients with high cholesterol in Phase 3 trial; results pave way for competition against cholesterol drugs by Amgen, Regeneron and Sanofi
Published:
August 29, 2023
by FierceBiotech
|
AstraZeneca and Sanofi's Beyfortus approved by FDA for prevention of RSV lower respiratory tract disease in infants up to 24 months; Beyfortus is the first preventive option approved to protect a broad infant population
Published:
July 17, 2023
by AstraZeneca AB
|
European Medicine Agency to monitor safety of GLP-1 diabetes and obesity treatments; Novo Nordisk, Eli Lilly, AstraZeneca, and Sanofi have until July 26 to provide additional information addressing cancer-associated concerns
Published:
July 05, 2023
by Indian Pharma Industry: Policies
|
Sanofi aims to become first pharma firm powered by AI at scale with launch of Plai app from Aily Labs; Sanofi incorporating AI in research, clinical operations and manufacturing.to streamline work processes
Published:
June 15, 2023
by FiercePharma
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count